Symproic (Purdue Pharma LP)
Welcome to the PulseAid listing for the Symproic drug offered from Purdue Pharma LP. This Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Purdue Pharma LP |
NON-PROPRIETARY NAME: | naldemedine |
SUBSTANCE NAME: | NALDEMEDINE TOSYLATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2017-03-23 |
END MARKETING DATE: | 0000-00-00 |
Symproic HUMAN PRESCRIPTION DRUG Details:
Item Description | Symproic from Purdue Pharma LP |
LABELER NAME: | Purdue Pharma LP |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 0.2(mg/1) |
START MARKETING DATE: | 2017-03-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 59011-523_0b82784a-f477-4107-9e4a-a1490a603262 |
PRODUCT NDC: | 59011-523 |
APPLICATION NUMBER: | NDA208854 |
Other NALDEMEDINE TOSYLATE Pharmaceutical Manufacturers / Labelers: